 Leuven, BE, Boston, MA, US March 31st, 2021 07.30 AM CET Oxurion NV Euronext Brussels: OXUR, a biopharmaceutical company developing next generation standard-of-care ophthalmic therapies, today announces its management will participate and meet one on one with investors at the following upcoming virtual meetings: 